Navigation Links
ICMR along with other International Research organisation with drug development for Neglected Diseases,,

Malaria, Tuberculosisand leprosy, are the world’s most neglected diseases along with diseases such as kala azar(leishmaniasis),sleeping sickness( human African trypanosomiasis)and Chagas disease, that afflict the deeply impoverished in developing countries and account for 90% of the global disease burden however ironically, a mere 10% of global health research is devoted to these diseases.//
In a laudable initiative, the Indian Council of Medical Research (ICMR), the Nobel Prize winning Organization Médecins Sans Frontières (MSF) and four eminent public research institutes from around the world have joined forces to address the lack of research and development in drugs for neglected diseases.This Drugs for Neglected Diseases initiative or DNDi, will work in close collaboration with WHO/TDR (Tropical Disease Research) program (1).
"Parasites don’t make headline news and they don’t make a profit, so despite TDR’s successes working with both the private and public sector, it has been difficult to find partners and increased investment for neglected diseases over the years," said Dr Carlos Morel, TDR (Tropical Disease Research) Director. "We are excited about collaborating with DNDi and hope that it will play a key role in raising awareness and investment and in speeding up the process of turning research into usable drugs for the most neglected diseases."

"Millions die each year from lack of effective, affordable drugs for curable tropical diseases," said Bernard Pecoul, Director of MSF’s Campaign for Access to Essential Medicines. In a press release from WHO it said that the world’s most neglected patients desperately need new, affordable, accessible and effective drugs, but their diseases do not represent a market profitable enough to attract Research and Development (R&D). Investment in drugs for neglected diseases is a mere trickle compared to the large amount invested in R&D for possible blockbuster drugs for diseases like cancer and hypertension, or lifestyle disorders such as impotence, obesity and baldness.

Some organizations from across the world are looking for solutions to ease the plight of the poor suffering from tropical diseases. DNDi’s six founding partners are primarily from the public sector and have already been working tirelessly in the field of public health and research. As DNDi, they will work with WHO/TDR, and use their existing capacity and global resources to address the needs of people suffering from neglected diseases by taking on drug development projects that others are unable or unwilling to pursue. DNDi, like WHO/TDR, will seek to strengthen existing R&D capacity in developing countries affected by the diseases.

Prof N.K. Ganguly, Director-General ICMR, an active member of DNDi’s Founding Partners group, explained, "India is an example of a country with both research and manufacturing capacity. Basically, products can be researched and manufactured in one developing country for use in another. Thus, it is crucial to collaborate across borders to ensure that those who need the drugs get them from those of us who can research and produce them."

DNDi has already initiated a successful worldwide call for research proposals and many scientists around the world are already researching new possibilities in drugs for neglected diseases. Theplan is that Over a 12 year period, DNDi will have a balanced project portfolio and six to seven projects registered for Chagas disease, sleeping sickness and kala - azar. The DNDi will be registered as a not-for-profit Organization in Geneva on 3 July 2003.

(1) UNDP/ World Bank/WHO Special Programme for Research and Training in Tropical Disease
'"/>




Related medicine news :

1. Help teenagers eat healthy by giving nutritional information along with food.
2. Grapefruit juice could be taken along with medication: the nutrient-drug reaction uncovered!
3. Another ray of hope for Arthritis Sufferers
4. Another injectable contraceptive Pill approved by FDA
5. Endangered species may be successfully cloned in another animals womb
6. Acupuncture May Help Chemotherapy Side Effects
7. Spouses and other partners lower blood pressure says new research
8. Radiotherapy helps in colon cancer
9. Allergies are related to mothers menses
10. Mothers with periodontitis may deliver premature babies
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/5/2016)... ... 2016 , ... United Benefit Advisors (UBA), the nation’s leading ... addition to its family of Partner Firms. Headquartered in Mount Pleasant, South Carolina, ... and health care consumerism specialists. , “Partnering with UBA will enable our firm ...
(Date:5/5/2016)... ... May 05, 2016 , ... Michael Lanteri Agency in ... to assist the people of their local community. The agency pledges to select ... leaders. Their hope is to bring awareness to important local causes with fundraising ...
(Date:5/5/2016)... ... May 05, 2016 , ... Tim Dieter ... serving families of greater Dubuque, IA. The current campaign fundraises for Veteran’s Freedom ... veterans. Donations to Veteran’s Freedom Center may now be made here: http://www.veteransfreedomcenter.com/donate/ ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... TIME for ... safety – today announced a new partnership to reach nearly 1 million children with ... in an instant and is the leading cause of accidental death in children one ...
(Date:5/5/2016)... ... ... The 2016 Nike Soccer Camp will be directed by the 2015 Big ... they bring their winning Vandals coaching philosophy to young athletes. Programs are offered for ... school players. Session dates are as follows: , Youth Day Camp – July 11th-14th, ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... , May 5, 2016 ... of the  "Europe Thalassaemia Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Thalassaemia Market and Competitive Landscape Highlights - ... products, Thalassaemia epidemiology, Thalassaemia market valuations and ...
(Date:5/4/2016)... upgrade. There are many medical recorders on the market but none like this. Through ...  offers unparalleled connectivity and functionality.  Ampronix  is a renowned authorized reseller of the medical ... Photo - http://photos.prnewswire.com/prnh/20160503/363416 ... ... ...
(Date:5/4/2016)... May 4, 2016 In ... a series of free workshops across ... requirements for Good Distribution Practices (GDP). Good ... ensures that products are consistently stored, transported and handled ... (MA) or product specification. Only a few years ago, ...
Breaking Medicine Technology: